The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of all universities in the world*
companies founded by graduates and faculty in the last 10 years
locations
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
An estimated 37 million people worldwide suffer from chronic kidney disease (CKD), with more than 2 million of them receiving dialysis as treatment. 90% of those on dialysis spend half their remaining lifetime hooked up to the machines and traveling to and from their dialysis clinic. In the interest of improving the quality of life for people with CKD, medical equipment manufacturer LiberDi (opens in a new tab) has created an at-home system that could replace traditional in-clinic dialysis.
Led in part by company CEO and Technion alumnus Hezekiah Tsoory, LiberDi’s Digital Dialysis Clinic uses peritoneal dialysis, a cheaper and less invasive method that utilizes the abdominal peritoneum as a filtering membrane for fluid and dissolved substances, which are exchanged with blood that is then cleansed and returned into the body. The needle-free system provides treatment for 20 to 25 minutes, which is much quicker than the 60 to 90 minutes for traditional dialysis. It monitors the patient’s performance of the fluid exchange and is designed to disinfect the catheter that is inserted into the patient’s abdomen.
Two Israel-based clinical studies showed the safety and effectiveness of the Digital Dialysis Machine on 42 patients in hospitals and at home. The study showed that just one 90-minute training session was necessary for caregivers to understand how to operate the system. The device also monitors the patients’ temperature and fluid output and then sends their data to the cloud, where it can be accessed by their healthcare practitioner.
LiberDi received regulatory clearance from the FDA last December and plans to bring the device to the U.S. market this year. They hope to sell the devices to hospitals so that they can train the patient and send them home with it for treatment. They also hope to expand commercialization in Israel, the U.S., and Europe.
March 29, 2023
Explore how dialysis is evolving with LiberDi's at-home system, transforming treatment for chronic kidney disease patients.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Alumni / Healthy Aging / Startups /
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
An Israeli medical researcher has helped shed new light on a mystery that has endured for nearly 340 years: what killed Queen Christina of Sweden, one of 17th-century Europe’s most unusual monarchs. Prof. Zaid Abassi of the Technion – Israel Institute of Technology’s, Ruth and Bruce Rappaport Faculty of Medicine and Rambam Health Care Campus, […]
Artificial intelligence is rapidly becoming an integral part of our lives, and a working tool for professionals in a variety of fields, including medicine, which integrates AI in order to reach faster, more accurate, and more efficient diagnoses. But to what extent can AI truly be relied upon when it comes to complex medical decisions? […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.